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ABSTRACT 
The present review article explains the salient features of hornet venom toxins, their physiological, biological and pharmacological effect on animals 
and man. Hornets sting very fast and inflict venom, which is more dangerous than those of bees. Hornet venom contains both proteinaceous and 
non-proteinaceous peptides i.e. scapin, adolapin, mellitin, mastoparans and enzymes, mainly phospholipase and hyaluronidase, which show 
multiple biological effects i.e. cytolytic, hemotoxic, neuro-inhibitor, anticancer, anti-parasitic, immune hypersensitive, inflammatory, antimicrobial 
and anti-insect activities. Hornet stings are more painful to humans than typical wasp stings because hornet venom contains a large amount (5%) of 
acetylcholine. Hornet toxin components interact with receptors, ion channels and gated channels and affect the permeability functions of cells. 
Heavy envenomation shows quick pathophysiological lethal effects in man and pet. This article emphasizes the use of various hornet venom 
components for the production of disease-modifying anti-rheumatic and analgesic, anticancer drugs and insecticides. Hornet venom allergens could 
be used to prepare the rational design of component-resolved diagnosis of allergy and venom immunotherapy of inflicting patients. 
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INTRODUCTION 
The hornets are hymenopteran insects belonging to genus Vespa. 
These are the largest social wasps, show similar appearance to their 
close relative’s yellow jacket wasps. Like wasps, hornets are also found 
almost in all parts of the world. The Asian giant hornet (Vespa 
mandarinia) is the world’s largest social wasp builds communal nests 
by chewing wood to make a papery pulp. Most of their species are 
flower visitors and collect nectar in the morning hours. The 
hornets are mostly of black to light black color and their size ranges 
4.3 to 5.5 cm (2.2 in) in length. They are distinguished from other 
vespine wasps by the relatively large top margin of the head and by 
the rounded segment of the abdomen just behind the waist. Hornets 
use stings to kill prey and defend hives. Hornet stings are more painful 
to humans than typical wasp stings because hornet venom contains a 
large amount of acetylcholine. Individual hornets can sting repeatedly, 
unlike honey bees; these do not die after stinging because their 
stingers are very finely barbed (only visible under high magnification) 
and can easily be withdrawn and so are not pulled out of their bodies 
when disengaging. The hornets are giant natural predators and play an 
important role in the balance of natural ecosystems through 
pollination, natural pest control and biodiversity [1].  
Hornet species found in Asia shows similarity in behavior and 
genetics to European hornet (Vespa crabo). This species is widely 
distributed throughout Europe, Russia, North America and 
Northeast Asia. Wasps native to North America belong to genus 
Dolichovespula are bald-faced hornets, but really they are actually 
yellow jacket wasps. So far, over 30,000 species of hymenopteran 
wasps have been reported, among which hornet 
biodiversity. Worldwide, shows 22 recognized species of genus 
Vespa [2]. The most common types of wasps or hornets, they build 
nest, which is housed by one queen, who lays eggs and is attended 
by workers. Workers are genetically sterile, cannot lay eggs. Most 
species make exposed nests in trees and shrubs, but some like Vespa 
orientalis build their nests underground or in wood or mud cavities. 
In the tropics, these nests may last year-round, but in temperate 
areas, the nest dismantle over the winter, with lone queens 
hibernating in leaf litter or other insulative material until the spring. 
Hornets are often considered pests, as they aggressively guard their 
nesting sites when threatened and their stings can be more 
dangerous than those of bees [3] (table 1). 
Source of information 
For writing this comprehensive research review on hymenopteran 
toxins/allergens, various databases were searched. For the 
collection of relevant information, specific terms such as medical 
subject headings (MeSH) and key text words, such as “venom 
allergens”, “biological and pharmaceutical effects”, therapeutic uses” 
published till 2020 were used in MEDLINE. Most especially for 
retrieving all articles pertaining to the use of VIT for insect venom 
allergy, electronic bibliographic databases was searched and 
abstracts of published studies with relevant information on the 
venom toxins/allergens were collected. Furthermore, additional 
references were included through searching the references cited by 
the studies done on the present topic. Relevant terms were used 
individually and in combination to ensure an extensive literature 
search. For updating the information about a subject and 
incorporation of recent knowledge, relevant research articles, books, 
conference proceedings and public health organization survey 
reports were selected and collated based on the broader objective of 
the review. This was achieved by searching databases, including 
SCOPUS, Web of Science, and EMBASE, Pubmed, PMC, Publon, 
Swissprot, Google searches” From this common methodology, 
discoveries and findings were identified and summarized in this 
final review.  
Venom composition 
Hymenoptera venom is a complex mixture of many substances such 
as toxins, enzymes, growth factor activators, and inhibitors (table 1, 
fig. 1). These are bioactive agents which impose deleterious effects 
in cells and tissues after venom infliction. Parasitic solitary wasps 
use bioactive venom components with the functions of prey 
inactivation and physiology manipulation. Wasp, bee and hornet 
toxins, mainly proteins, show hemolytic and immune-
stimulatory effects (table 1). Venom of Neoponera villosa induces 
hemolysis in human erythrocytes and also induced release of both 
pro-inflammatory cytokines, as the anti-inflammatory cytokine 
release by murine macrophages [4]. The various Vespa species 
venom contains kinins, polyamines and hornetin, which showed 
cytotoxic and anticancer activities (table 1). Vespa vulagaris secrete 
hyluronidase A an enzyme that is highly allergenic and shows 
cytotoxic activity. Bees also secrete acid phosphatase that acts as a 
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coagulation factor and show antimicrobial activity (table 1, fig. 1). 
Hornet venom contains enzyme phospholipase, acid phosphatase, 
and various phospholipases, appear to be relatively more specific to 
the social wasp venom (table 1). Hornet venom binds to a large 
number of proteins and receptors and imposes pathophysiological 
changes in victims. These enzymes cause the disruption of cellular 
membranes and induce hypersensitive reactions, including life 
threatening anaphylaxis. Moreover, phospholipase A2 is a major 
component of bee venoms, while phospholipase A1 (PLA1) is highly 
abundant in wasps and ants. Common components in both solitary 
and social wasp venoms include hyaluronidase, phospholipase A2, 
metalloendopeptidase (table 1, fig. 1). These enzymes trigger an 
immune response, inducing IgE response in susceptible 
individuals [5]. Some neurotoxic peptides (e. g., pompilido toxin and 
dendrotoxin-like peptide), proteins (e. g., insulin-like peptide-
binding protein) and allergens also found in solitary wasp venom. 
Similar to venom found in most venomous animals, parasitoid 
venoms contain a complex cocktail of proteins with potential 
agrochemical and pharmaceutical use (table 1, fig. 1). 
Enzymes 
Phospholipase B (PLB) 
Phospholipase B (PLB), also known as lysophospholipase, is an enzyme 
found in very low concentrations in hornet venoms. Phospholipase A2 
(PLA2) is a calcium-dependent enzyme that hydrolyzes the Sn-2 ester of 
glycerol phospholipids to produce a fatty acid and a lysophospholipid. It 
destroys phospholipids, disrupting the integrity of the lipid bilayers, thus 
making cells susceptible to further degradation. In fact, PLA2 reaction 
products, such aslysophosphatidyl choline, lysophosphatidic acid and 
sphingosine 1-phosphate, can have cytotoxic or immune stimulatory 
effects on diverse cell types, causing inflammation and immune 
responses [6]. With the capacity to cleave acyl chains from both sn-1 
and sn-2 positions of a phospholipid, PLB shows a combination of PLA1 
and PLA2 activities. Hyaluronidase is commonly known as a “spreading 
factor” because it hydrolyzes the viscous polymer hyaluronic acid into 
non-viscous fragments. It also acts as an allergenic agent (table 1; fig. 1). 
When an extracellular matrix is destroyed by hyaluronidase, the gaps 
between cells facilitate the invasion of venom toxins (fig. 1). Therefore, 
venom penetrates in tissues and enters blood vessels, thus catalyzing 
systemic poisoning. Furthermore, hydrolyzed hyaluronan fragments are 
pro-inflammatory, pro-angiogenic and immune stimulators, thus 
inducing faster systemic envenomation [7]. 
Mast cell degranulating (MCD) peptide 
Mast cell degranulating (MCD) peptide is cationic in nature, having 
22 amino acid residues. It shows a similar structure to albumin. It is 
cross-linked by two disulphide bond [8]. This peptide is a potent 
anti-inflammatory agent; at low concentration, it is a strong 
mediator of mast cell degranulation and histamine release from 
mast cells, which are present in the blood supply and in all 
tissues perfuse by blood [9] (table 1; fig. 1). 
Bradykinin 
Bradykinin is a physiologically active peptide that belongs to the kinin 
group of proteins. Bradykinin and related kinins act on two receptors, 
designated as B1 and B2 (table 1). The former is expressed only as a 
result of tissue injury and it is thought to play a role in chronic pain. In 
contrast, the B2 receptor is constitutively expressed, participating in 
vasodilatation via the release of prostacyclin, nitric oxide, and 
endothelium-derived. Hyperpolarizing factor contributes lower blood 
pressure [10] (table 1; fig. 1). 
Adolapin 
Adolapin is a peptide that exerts a potent analgesic and anti-
inflammatory effect in rats and blocks prostaglandin activity [11]. 
Tertiapin, also from bee venom, is a 21 amino acid peptide that 
blocks certain types of inwardly rectifying potassium channels [12] 
(table 1; fig. 1). 
Scapin A 
The peptides Scapin-1, and Scapin-2 are all 25 amino acid residues 
in length and share a similar secondary structure, with a disulfide 
bridge between Cys 9 and Cys 20. These peptides have been isolated 
from the venom various species, such as Scapin from European 
Apis mellifera [13]. Scapin-1 from Chinese Apis mellifera [14] and 
scapin-2 have been isolated the Africanized honey bee [15] (fig. 1, 
table 1). 
Apamin 
Apamin is bee venom peptide that acts as a neurotoxin and induces 
multiple physiological effects. Albumin acts mainly on the CNS. It 
blocks Na+K+ channels; in neurons and binds with high affinity to 
post-synaptic membrane receptors and causes hyper-polarization of 
adrenergic, cholinergic and purinergic nerve fibers. It also generates 
neurotensin-induced effects and blocks post-synaptic functions but 
does not show any lytic activity in mammalian cells [16] (table 1). 
Proteases  
Protease is an enzyme having high levels of proteolytic activity 
in connective tissues [17] and cause moderate necrosis [18]. It 
also occurs in venom of social wasp (Polistes infuscatus), Vespa 
orientalis [19] Polybia paulista, Polybiaignobilis, Agelaia pallipes 
pallipes, Apoica pallens and ant (Eciton burchelli) [20]. These 
insects also contain several isoenzymes, which are responsible 
for caseinolytic and gelatinolytic activities [21]. Bombus venom 
protease in association with PLA2, HYAL, and acid phosphatase 
havetrypticamidase specificity and having strong allergenic 
reactions. Bombus species such as Bombus impatiens, Bombus 
fraternus, and Bombus bimaculatus also exhibit trypticamidase 
activity [22], coagulant, [23] and hemorrhagic activities [24] 
(table 1). 
Mastoparan-C (MP-C) 
Wasp venoms also contain small molecules, such as minerals, amino 
acids, and physiologically active amines, such as catecholamines. 
Histamine is a major organic nitrogenous compound found in wasp 
venom that participates in the inflammatory response by increasing 
the permeability of capillaries. Few species of wasps such as 
Ropalidia,Vespa xanthoptera, Vespa ducalis and Vespula lewisii 
secrete mastoparan molecules that cause allergic inflammation and 
does mast cell degranulation in mammals (table 2, fig. 2). Different 
species of Yellowjacket wasps i.e. Vespa flavopilosa, Vespula vidua, 
Vespula lewisii, Vespula pensylvanica and Vespula squamosa secrete 
allergen 5 in their venoms which show anticancer activity (table 2, 
fig. 2). In addition, Vespa orientalis, Paravespula maculifrons, Vespa 
xanthoptera and paper wasp Polistes exclamans kinins are 
responsible for severe pain production and act as neuro-inhibitors 
(table 2, fig. 2). 
Catecholamines, dopamine and nor-adrenaline increase heartbeat, 
thereby enhancing venom circulation and thus, its distribution [25]. 
Serotonin is a strong irritant that evokes contribute pain caused by 
venom. Finally, high levels of Acetylcholine increase perceived pain 
of a sting by stimulating pain receptors synergically with histamine 
effects. The black-bellied hornet (Vespa basalis) possesses highly 
toxic venom which is rich in toxin, enzymes and biologically active 
peptides. It also contains mastoparan B, protease and serotonin, 
which showed chemotactic activity on human neutrophils. These 
peptides also exhibit potent hemolytic activity. Serotonin imposes an 
edematous effect on victims. Mastoparan B is a cationic tetra 
decapeptide isolated from Vespa basalis show strong edematous and 
hemolytic activities. This hemolytic and edema-inducing activities of 
MP-B, is due to presence of Lys2 amino acid and Trp9 rupture 
membrane and generate hemolytic activity [26] (table 2, fig. 2).  
Biological activities 
Hymenopteran insects inflict a large amount of venom in the victim 
that causes massive inflammation, swelling and pain. It obstructs 
respiration due to extensive swelling of the tracheal region [27] and 
how very high lethality and systemic reactions after envenomation 
[28]. Usually, bees stung victims survived high in number [29] but 
sometimes stinging occurs in the neck region blocks respiration due 
to tracheal swelling. Severity of venom increase with increases in the 
quantity of venom injected [30]. Lethality increases with the age [31, 
32] venom toxin hardly acts upon liver and kidney cells that make 
metabolic alterations in the body [33], B lymphocytes, secrete a 
group of immunoglobulins and release γ interferons. Each 
immunoglobulin released from B-lymphocyte recognizes different 
epitopes and bind selectively [34-38]. Melittin is a major toxic 
component found in bee venom show diverse biological activity [39] 
(table 3, fig. 3). Similarly, venom of A. dorsata, A. serene and A. florae 
exhibited nearly identical lethal dose [40, 41]. Hornets deliver just a 
typical insect sting, while others are among the most venomous 
known insects. Single hornet stings are not in themselves fatal, 
except sometimes to allergic victims. Individual hornets can sting 
repeatedly; unlike honey bees, hornets do not die after stinging 
because their stingers are very finely barbed (only visible under 
high magnification) and can easily be withdrawn and so are not 
pulled out of their bodies when disengaging. Hornet venom imposes 
allergen-specific reactions and also regulates immune responses and 
makes physiological changes [42] (table 3, fig. 3).  
Hornet stings are more painful to humans than typical wasp stings 
because hornet venom contains a large amount (5%) of 
acetylcholine (table 2). Hornets attack very fast in groups and use 
stings to kill prey and defend hives. Asian giant hornet (Vespa 
mandarinia) inflicts venom very quickly and cause human fatalities 
in Asian countries [43]. Its toxicity depends on the sting and and 
volume of venom injected into the host, and varies according to 
hornet species. Asian giant hornet venom can cause allergic 
reactions and multiple organ failure leading to death, though dialysis 
can be used to remove the toxins from the bloodstream. Allergic 
reactions are commonly treated with epinephrine (adrenaline) 
injection using a device such as an epinephrine auto-injector, with 
prompt follow-up treatment in a hospital. In severe cases, allergic 
individuals may go into anaphylactic shock and die unless treated 
promptly [44]. Hornets possess black and white with yellow head 
strips. Single hornet stings are not in themselves fatal, they cause 
allergic reactions in victims [45]. 
Peptides isolated from bees and wasps i.e. tropomyosin from 
Orancistro cerus, drewsen, iRhynchium brunneum, paramyosin from 
Orancistro cerus drewseni, Rhynchium brunneum, myosin from 
Eumenes pomiformis  affect muscle contraction and assembly of 
contractile machinery in muscle cells (table 3; fig. 3). Chemotactic 
peptide and mastparan like peptide secreted from Cyphononyx 
fulvognathus wasp venom showed inflammatory activity due to the 
presence of kinins and polymanines (table 3; fig. 3). Eumenes 
pomiformis secrete dendrotoxin that is responsible for K+channel 
blocking, while Anopliussa mariensis secrete α-pompilidiotoxin, 
Batozonellus maculifrons β-pompilidiotoxin cause paralysis and block 
Na+ channels (table 3; fig. 3). Vespa affinis stings cause complications 
such as myocardial infarction and multiple organ failure. 
Hornet toxins, increase microvascular permeability and acute 
pulmonary edema as the primary pathology after envenoming (table 
3; fig. 3). Early recognition of acute pulmonary edema in hornet 
stings is needed more appropriate diagnosis, more often high-
quality treatments to avert deaths (table 3).  
The wasp, Agelaia pallipes pallipes is one of the most aggressive 
species the Neotropical region, causing many stinging accidents every 
year, characterized by severe envenoming reactions. These peptides 
presented activity related to mast cell degranulation, hemolysis, or even 
the chemotaxis of leukocytes [46]. The P. paulista venom contains eighty-
four venom proteins. The wasp stings action starts with the diffusion of 
venom through the tissues and and to the blood, it is followed by tissue 
hemolysis, inflammation, and allergy-played by antigen-5, PLA1, 
hyaluronidase, HSP 60, HSP 90, and arginine kinases [47]. Peptides 
isolated from the venoms of the honey bee (Apis mellifera) and the social 
wasps Polybia paulista and Proto nectar in asylveirae showed 
nociceptive (hyperalgesic) and edematogenic effects. Its venom 
possesses peptides Melittin (Apis mellifera), Polybia-MP-I, N-2-Polybia-
MP-I N-2-Polybia-MP-I (Polybia paulista), protonectarina-MP-NH2 and 
Protonectarina-MP-OH (Protonectar in a sylveirae) [48] (table 3; fig. 3).  
Hymenopteran stings induce uncontrolled inflammation that results 
in extensive tissue damage and IgE-mediated hypersensitivity 
reactions. Venom allergens cause local reactions to severe pain and 
intense pain. [49]. Inflammatory response initiates with the release 
and activation of pro-inflammatory cytokines and other mediators, 
such as nitric Oxide. Cytokines play important roles in mediating cell 
recruitment and activation necessary for inflammation and repair of tissue 
damage. Few lepidopteran insects impose allergic urticaria dermatitis and 
atopic asthma, coagulopathy, renal failure, and intra cerebral hemorrhage 
[50]. Eicosanoids mediate inflammation. Melittin acts as an anti-
inflammatory drug as they have the capacity to inhibit PLA2 activity 
[51].]. It behaves much better than non-steroidal drugs, 
methotrexate, and other biological disease-modifying anti-rheumatic 
drugs [52, 53]. Bee venom shows protective and anti-inflammatory 
properties [54]. Normally, wearing of protective clothing reduce the 
risk of venomous stings, inflammation and pain (table 3). Polybia-MP1 
(IDWKKLLDAAKQIL-NH2) is a lytic peptide from the Brazilian Wasp 
venom with known anti-cancer properties [55]. The venoms of bees, 
wasps, hornet, spiders, and scorpions possess pharmacologically 
active molecules which show anti-tumor and anti-cancer activity [56, 
57] (table 3; fig. 3).  
Melittin inhibits tumor cell growth and induces apoptosis. It could 
be used as a potential alternative or complementary medicine for 
the treatment of human cancers [58]. It acts as a natural detergent 
with the capacity to form, tetramer aggregates on membranes, 
which lead to disorders in the structure of phospholipid bilayers, 
changes in membrane potential, aggregation of membrane proteins, 
as well as the induction of hormone secretion [59]. Furthermore, 
this membrane disruption directly or indirectly leads to alterations 
in enzymatic systems, such as G-protein [60], protein kinase [61], 
adenylcyclase [62] and phospholipase [63]. Melittin can even inhibit 
calmodulin, a calcium-binding protein that plays a crucial role in cell 
proliferation [64]. Tumorous cells expose anionic phospholipids, 
mainly Phosphatidylserine, on the external leaflet of the plasma 
membrane [65]. Melittin displays anti-proliferative activity [66] and 
inhibit angiogenesis at cancerous sites [67]. Melittin-based 
recombinant immunotoxins prepared after fusion of genes that 
encoded an antibody fragment derived from the murine monoclonal 
Antibody K121 found effective in vitro [68]. Recombinant 
immunotoxin of melting Fused to an anti-asialo glycoprotein 
receptor (ASGPR) a single-chain variable fragment antibody (CA) 
shows anti-invasive activity in hepatocellular carcinoma cells [69]. 
More specifically, CTLA-4-targeted scFv-melting fusion protein acts 
as a potential immunosuppressive agent showed selective 
cytotoxicity assist in organ transplants [70]. Melittin coupled to 
avidin, when released induces immediate cell lysis [71] and stop 
cancer cell latency [72] (table 3; fig. 3). 
Anti-parasitic activity 
Insects possess anti-parasitic peptides, which show the much wider 
application in drug therapy. Both host insects and general 
arthropods, which live in association and co-exist with parasites, 
secrete anti-parasitic compounds. These compounds are used as an 
alternative medicine for the treatment of protozoa-related diseases, 
mainly caused by endemic parasites i.e. Leishmania sp., Plasmodium 
sp., and Trypanosomes [73]. AMPs isolated from crude animal 
venoms/secretions from bee/wasp venoms showed potential to 
treat protozoan-borne diseases [74] and become a new class of anti-
malarial drugs. These antimicrobial peptides (AMP) derived from 
insect venom have multiple therapeutic use. Bee venom AMPs 
(anoplin, duramycin, mastoparan X, melting, TP10 and Vida3) 
specifically target sporogonic stages of Plasmodium for toxicity 
against a mosquito cell line and P. bergheiookinetes [75]. More 
exceptionally anoplin and mastoparanX, were found toxic in an 
Anopheles gambiae cell line at a concentration of 25 µM. Most AMPs 
affect membrane integrity and produce lethal pores in 
microorganisms, including protozoan pathogens, whereas others act 
on internal targets or by modulation of the host immune system.  
These antimicrobial peptides successfully kill malaria parasites, 
Plasmodium spp., in their blood or mosquito stages, or both [76]. 
Venom Peptides from parasitoid wasps show strong anti-parasitic 
potential [77]. Venom components of Asobara japonica impair 
cellular immune responses of host Drosophila melanogaster. The 
endoparasitoid female wasp Asobara japonica naturally injects 
toxins that kill Drosophila larvae and Insecticidal venom is 
neutralized [78, 79] (table 3; fig. 3).  
Antimicrobial activity 
Antimicrobial peptides (AMPs) have been widely studied as an 
alternative to conventional antibiotics, especially for the treatment 
of drug-resistant infections [80]. Melittin shows strong antimicrobial 
properties due to its hemolytic nature. This venom peptide involves 
interactions with the lipid groups of the membrane [81, 82] and 
forms pores in the membrane and operate from various cellular 
actions such as orientation and aggregation states [83]. A hybrid 
undecapeptide derived from the well-known cecropin A and melittin 
showed antifungal and antibacterial activities. It also displays low 
cytotoxicity [84] similar to retro and retro-enantio analogs [85]. It 
also acts as an antibiotic and anti-malarial agent [86]. Despite the 
therapeutic efficacy of antimicrobial peptides, they show poor 
bioavailability in vivo caused by instability, cytotoxicity and 
hydrophobicity [87]. Antimicrobial peptides are also applied for 
fighting economically important plant pathogens [88]. In this 
category linear undecapeptides derived from cecropin-Melittin 
hybrids have been tested against phytopathogenic bacteria [89]. A 
peptide BP76 is also used for phytosanitary compositions [90]. 
Novartis has patented a method to produce contact lenses with an 
antimicrobial metal-containing layer-by-layer (LbL). In its 
Label design, at least one layer has a negatively charged polyphonic 
material, having-COO-Ag groups or silver nanoparticles. Melittin and 
its analogs display antiviral activities that are caused due to the 
selective reduction of the biosynthesis of some viral proteins. It is 
reported for the Melittin analog Hecate on herpes virus-1 [91] and 
strong melittin action on HIV-1-infected lymphoma cells [92]. 
Previously melittin was present to provide an 
improved composition complementary to azidothymidine (AZT) to 
inhibit the reverse transcriptase and growth of HIV-infected cells 
[93]. Melittin is also carried in a nanoparticle construct designed to 
be used as a topical vaginal virucide [94]. More specially, cationic 
antimicrobial peptide anoplin are lipophilic in show hemolytic 
activity and proteolytic stability [95]. AMPs from insect venom are 
antimicrobial"weapons" are promising antimicrobial Agents [96]. 
MP-V1 from the Venom of Social Wasp Vespula vulgaris displays 
much higher antimicrobial activity [97] (table 3; fig. 3).  
Phospholipase A1 (vPLA1) from the black-bellied hornet (Vespa 
basalis) catalyzes the hydrolysis of emulsified phospholipids and 
shows potent hemolytic activity that is responsible for its lethal 
effect (table 3). AMPs from insects could be used as peptide 
antibiotics [98]. These could be used one kind of ideal alternatives of 
Synthetic pesticides and the development of novel antimicrobials. 
Nine different AMPs were isolated from the venom gland of the wasp 
Vespa tropica. These AMPs have been classified into two different 
families based on sequence similarity, mastoparan and vespid 
chemotactic peptides (VCPs), and named as mastoparan-VT1 to-VT7, 
VCP-VT1 and-VT2 [99]. Among these nine AMPs, mastoparan-VT1 
and VCP-VT1 are identical to peptides from other wasps. These nine 
AMPs, mastoparan-VT1 and VCP-VT1 are identical to peptides from 
other wasps. These AMPs exerted broad-spectrum antimicrobial 
activity [100] (table 3; fig. 3). 
Antiviral activity 
The venoms of bees and wasps are complex mixtures of biologically 
active proteins and peptides, such as phospholipases, hyaluronidase, 
phosphatase, β-glucosidase, serotonin, histamine, dopamine and 
nor-adrenaline [101]. Bee venom and its components, 
i.e. melting (MLT), phospholipase A2 (PLA2), and albumin showed 
inhibitory effects against viruses, i.e. Influenza A virus (PR8), 
Vesicular Stomatitis Virus (VSV), Respiratory Syncytial Virus (RSV), 
and Herpes Simplex Virus (HSV) in vitro and in vivo [102]. Bee 
venom toxin peptide mastoparans and its derivatives show broad-
spectrum antiviral activity against enveloped viruses [103]. More 
especially, mastoparan-derived peptide MP7-NH2 could inactivate 
viruses of multiple types and activate cell-mediated antiviral 
immune responses. Moreover, melittin a venom-derived peptide 
isolated from European honey bee Apis mellifera show anti-viral 
activity against human immunodeficiency virus (HIV) [104, 105]. It 
also demonstrates anti-cancer, anti-inflammatory, anti-diabetic, 
anti-infective, and adjuvant properties. Melittin also curbs infectivity 
of a diverse array of viruses, including coxsackie virus, enterovirus, 
influenza A viruses, human immunodeficiency virus (HIV), herpes 
simplex virus (HSV), Junín virus (JV), respiratory syncytial virus 
(RSV) Vesicular stomatitis virus (VSV), and tobacco mosaic virus 
(TMV). This peptide-based therapeutics are found effective against 
Human immunodeficiency virus (HIV), Influenza virus and Hepatitis 
virus B and C [106] (table 3; fig. 3).  
Proteolytic activity 
Trophallactic fluid secreted from larvae of wasps (subfamily-
vespinae) possesses multi-cellular organisms. Larvae exhibit the 
capacity to fully digest and metabolize proteins [107] (fig. 1). 
Analgesic activity 
Normally opioid drugs are used as analgesics for sequential 
treatment of pain. Mastoparan Agelaia-MP I abundant class of 
peptides found in wasp venom. These show dose-dependent anti-
nociceptive activity in mice. Agile-MP I induced partial and 
reversible blockade of the amplitude of action potential, probably 
interacting with voltage-gated sodium channels. It shows a 
significant potential impact on the central nervous system (CNS) 
[108]. Both melittin and albumin showed the anti-nociceptive effect 
to degenerative diseases of the nervous system. Venom enzymes and 
peptides show natural stability as an injectable solute, they also 
possess ability to synergize their actions by enhancing cell–cell 
interactions [109] (fig. 2). 
Anti-diabetic  
Diabetes is a metabolic disorder characterized by hyperglycemia 
resulting from perturbations in insulin secretion, insulin action or 
both. Diabetes, type 2 results in highest mortality rate worldwide. It 
occurs due to abnormal insulin secretion and patients display a state 
of impaired glucose tolerance to frank type 2 diabetes [110, 111]. 
For treatment of this storage disease/disorder insulin release 
mechanism is applied by injecting toxins isolated from animal 
venoms [112]. Venom toxin peptides induce electrical activity of the 
ion channels present in pancreatic β cells that are involved in the 
insulin secretion process. These interact and modulate the electrical 
activity of pancreas cells. It interacts and induces molecular, cellular 
and physiological mechanisms of insulin granule biogenesis. This 
initiates with the synthesis of pre-proinsulin in the rough 
endoplasmic reticulum and the conversion of pre-proinsulin to 
proinsulin. Proinsulin begins to be packaged in the Trans-Golgi 
Network and is sorted into immature secretory granules. These 
immature granules become acidic via ATP-dependent proton pump 
and proinsulin undergoes proteolytic cleavage that results in 
formation of insulin and C-peptide. During the granule maturation 
process, insulin is crystallized with zinc and calcium in the form of 
dense-core granules. It stops degradative pathways of insulin 
secretion and dense-core insulin granule synthesis in affected cells 
[113]. Apis mellifera bee tea showed anti-hyperglycemic and anti-
diabetic activity [114] (table 3; fig. 3). Similarly, Iranian Honeybee 
(Apis mellifera) venom affect blood glucose and insulin in diabetic 
rats [115]. 
Antiseptic activity 
Bracon hebetor, an ectoparasitoid showed dose-dependent abrogation 
of nitric oxide (NO) production. It suppresses the levels of pro-
inflammatory mediators and cytokines without posing any 
cytotoxicity via the nuclear factor kappa B (NF-kB) and mitogen-
activated protein [116]. Insect venom toxins show very strong action 
against human pathogens, which could act as anti-septic agents (table 
3). Insect venom toxins are biologically active natural products [117] 
which could become a natural source of analgesics [118] (fig. 2).  
Anti-oxidative activity 
Bee Venom suppresses high fat diet-induced obesity by inhibiting 
adipogenesis. It enhances fat desorption [119]. Mastoparan-B is a 
toxin peptide isolated from the venom of Vespa basalis the most 
dangerous hornet found in Taiwan. MP-B, influences of mast cell 
degranulation and hemolytic activities (table 3). It acts as an 
antioxidant at low concentration in competing with nitric-
oxide oxygen molecules and possesses good anti-oxidative enzyme 
activities resembled to superoxide dismutase and glutathione 
peroxidase [120] (fig. 2).  
Cytogenotoxic effects 
The venoms of wasps are a complex mixture of biologically active 
low molecular mass compounds, peptides, and proteins (table 3). 
Venoms of Polybia occidentalis and Polybia fastidious act on the 
human leukocytes DNA and inhibit cell cycle. It severely affect 
constitution of genetic material in plant model Lactuca sativa L. 
(lettuce) [121] (fig. 2).  
Insecticidal activity 
Hymenoptera insects possess complex mixtures of toxins in its 
venoms which are used for self-defense, to repel intruders and to 
capture prey. These selectively target receptors found on brain cells 
of insects and stop insect movements. These could be used as good 
source for new insecticidal compounds for making new, 
highly potent drugs. Several insecticidal peptides or polyamine-like 
compounds have been purified and characterized from the venom of 
arachnids and hymenopterans [122]. These are used as bio-
insecticides for insect control [123]. Venom toxin peptides show 
catalytic activity and form pores in biological membranes [124]. 
Peptides isolated from the venom of social Wasp Charter gellus 
communis (Hymenoptera: Vespidae) show hyperalgesic, edematogenic 
and hemolytic effects. Wasp origin peptides and proteinaceous toxins 
target voltage-gated sodium (NaV) channels could be used as 
pharmacological tools [125, 126]. Toxin-based bioactive drugs are 
mainly prescribed [127] for anaphylaxis and fatal sting management 
[128, 129]. It is also used in clinical treatments for V. velutina induced 
toxic reactions and allergic effects [130]. Hymenoptera venom 
allergens are also used for the rational design of component-resolved 
diagnosis of allergy, mainly for improving the outcome of venom 
immunotherapy (VIT) [131] (table 3, fig. 3).  
Therapeutic uses 
Melittin, hyaluronidase and PLA2 are the main component of bee 
venom which impose allergic reactions in man [132]. Melittin is an 
amphiphilic peptide comprising 26 amino acid residues, its amino-
terminal region is predominantly hydrophobic and, the carboxyl-
terminal region is hydrophilic. Melittin is the principal active 
component of apitoxin and is responsible for breaking up and killing 
cells. When several melittin peptides accumulate in the cell 
membrane, phospholipid packing is severely disrupted, thus it 
leading to cell lysis [133, 134] fig. 3). Melittin triggers not only the 
loss of a wide range of plasmatic membranes, but also of 
intracellular ones such as those found in mitochondria. PLA2 and 
melittin act synergistically, breaking up membranes of susceptible 
cells and enhancing their cytotoxic effect [135] Melittin induced cell 
damage, in turn, may lead to the release of other harmful 
compounds, such as lysosomal enzymes from leukocytes, serotonin 
from thrombocytes, and histamine from mast cells, which can all 
lead to pain ((table 3; fig. 3). Melittin is the most known bee venom 
peptide that is widely used in so many clinical applications. It acts as 
an immunologic adjuvant and therapies used for the treatment of 
rheumatoid arthritis, arteriosclerosis, cancer, and endosomolytic 
properties for drug delivery. It strongly acts like as an antibiotic and 
help to finish microbial infections. It is also used in antiretroviral 
therapy to reduce the passage of HIV-1 and to limit the viral load in 
infected people [136]. Both Melittin and its analogs are capable of 
eliciting strong immune responses against viral antigens. These 
reduce the risk of toxic side effects associated with the use of 
adjuvant [137]. Macrophages secrete pro-inflammatory cytokines, a 
main cellular component in the development of atherosclerotic 
plaques [138]. It dissolves atherosclerotic plaques formed in blood 
vessels and is used for the treatment of atherosclerosis [139, 140]. 
This molecular mechanism of the anti-atherosclerotic effects 
of melittin is established in mice models [141] (table 3; fig. 3).  
Albumin is a peptide neurotoxin comprising 18 amino acid residues 
that tightly cross-linked by the presence of two disulphide bonds 
[142]. It shows many hyperpolarising-inhibitory effects, including 
alpha-adrenergic, cholinergic, purinergic, and neurotensin-induced 
relaxations [143]. Unlike melittin, apamin is a peptide with a highly 
specific mode of Action. It binds and occludes the pore of small 
conductance Ca2+-triggered K+channels (SK), thus acting as an 
allosteric inhibitor [144] and depressing delayed cell 
hyperpolarization. This binding specificity of albumin and its 
electrical properties could be exploited in biomedical research. 
Albumin acts mainly on the CNS, where SK channels are widely 
expressed [145] (fig. 3). SK channels are of three types based on 
their conductance and third small conductance (SK or K3) [146]. 
These channels are activated solely by increase in intracellular 
Ca2+contribute to regulating the excitability and function of many 
cell types, including neurons, epithelial cells, T-lymphocytes, and 
skeletal muscle cells [147]. SK channels are activated by sub 
micromolar concentrations of Ca2+, and this activation is mediated 
by calmodulin [148]. In excitable cells, the activation of SK channels 
generates a hyperpolarizing K+current which contributes to the 
after hyperpolarisation (AHP) that follows an action potential. This 
AHP modulates cell firing frequency and spike frequency adaptation, 
thereby influencing neuronal excitability. SK channels have been 
implicated in diverse physiological functions such as synaptic 
enhancement and long¬ term potentiation. Apamin injections 
accelerate acquisition of the bar-pressing response and also 
accelerate bar-pressing rates [149, 150]. Wasp and honey bee and 
hornet toxin peptides because convulsions due to presence of 
albumin a rigid octadecapeptide but it is no longer be considered an 
exclusive neurotoxin. [151]. Contrary to this apamin is show cellular 
toxicity in vital organs [152, 153] (table 3; fig. 3). 
Hymenoptera venom allergy 
Allergen immunotherapy (AIT) is used to desensitize the allergen 
injected by venomous insects. It successfully switches off the allergy 
over time and become an effective treatment for allergies to bee and 
wasp stings [154]. It is mostly used to stop systemic allergic sting 
reactions. This is also used for the treatment of chronic 
inflammatory disease, especially arthritis. Hymenoptera venom 
proteins and peptides are used for Diagnosis and treatment of 
venom allergic patients [155]. In allergen immunotherapy, hypo 
sensitization are considered for therapeutic purposes by 
changing the dose level. The effect depends to some degree on the 
original intensity of hypersensitivity [156]. Hypersensitivity is 
mostly developed in beekeepers because of frequent exposure of 
honey-bee stings. This long-term exposure to venom toxins induces 
immune tolerance in them. This is the main reason that the 
prevalence of systemic reactions to bee stings in beekeepers is very 
low (approximately 14% to 42%) while very high immune tolerance 
(67-90%) is observed due to continued exposure of toxins. All it 
happens after adaptive immune responses in them [157] (table 3; 
fig. 3). 
Apitherapeutics 
Apitherapy is an alternative therapy in which honey bee products 
are directly used against honey bees. Apitherapy is used to treat 
multiple sclerosis, arthritis, infections, and shingles. It is used to 
treat illnesses wounds, burns, tendonitis as well as pain and acute 
and chronic injuries. In Apitherapy, honeybee products are applied 
topically, or intake orally, or provided injection. Apitherapists 
promote the medical use of products from the beehive (bee venom, 
propolis, pollen, honey, royal jelly and dead bees. It is also a fact 
that the majority of patients show un-willingness to apitherapy 
because they feel that they cannot tolerate such treatments. 
Therefore, therapeutic modifications are needed for increasing 
acceptability [158] (table 3; fig. 3). It is true that significant numbers 
of modern-day pharmaceuticals are derived from natural products, 
mainly venoms of various origins show therapeutic potentials. In the 
present time due to the increasing rate of drug resistance of the 
pathogen organisms and target cells as well as the dependence or 
tolerance of the body towards the drug, venom toxins are seen novel 
candidates for making pharmaceutical agents. Wasp venoms are also 
a rich source of therapeutically important toxins, which includes 
short cationic peptides, kinins, polyamines and poly DNA viruses. 
These have diverse therapeutic significance. 
Mode of action 
Insect toxins comprise a diverse array of chemicals ranging from 
small molecules, polyamines and peptide toxins. Many target 
nervous systems and neuromuscular ion channels and so rapidly 
affect the behavior of animals to which the toxin is applied or 
injected. Other modes of action have also been identified. Wasps, 
bees, flies, and ants generate a rich arsenal of channel-active toxins, 
some of which offer selective pharmacological probes that 
target particular ion channels, while others act on more than one 
type of channel. Philanthotoxins from the digger wasp target ligand-
gated ion channels, both in the nervous system and at 
neuromuscular junctions. Apamin from bee venom targets calcium-
activated potassium channels, which can in turn influence their lease 
of neuropeptides. Melittin acts on the membrane surface. 
Mastoparan is a powerful peptide toxin present in the venom of 
wasps. Its toxic actions can be engineered out, leaving a potent 
antimicrobial molecule of interest. Hymenopteran wasps contain 
albumin that interacts neuronal receptors and play an important 
role in prey paralysis in small insects [159]. This interaction may 
play a crucial role in most of the cellular process; formation of 
complexes, binding specificity could be utilized for the design 
molecules [160]. The crude honey bee (Apis mellifera) venom also 
acts on the skeletal, smooth as well as cardiac muscles. It also shows 
neurotoxicity of inhibitory nature involving the autonomic as well as 
neuromuscular system [160]. This secretory phospholipases A2 
(sPLA2s) have specific receptors in brain membranes called N-type 
receptors. It binds to the N receptor recognition domain of the toxin. 
Neo nicotinoids are agonists of nicotinic acetylcholine receptors; 
they disturb acetylcholine receptor signaling leading to 
neurotoxicity. The main element which imposes this neurotoxicity is 
Phospholipase A2 that displays N-type receptor binding. Bee venom 
toxins also bind to to cell surface receptors, ion channels and ion 
gated channels or by passive diffusion by making pinholes in cellular 
parasites [161](fig. 3). Honey bee venom, shows induction of 
apoptosis in malignant cells [162]. It shows the inhibitory, anti-
invasive and cytotoxic effect on several types of cancer lines [163]. 
Bee venom components melittin shows showed anti-proliferative 
and anti-metastatic properties and apoptosis in malignant glioma 
cells [164, 165] (fig. 3). These stops progression of cancer and 
inhibit metastasis in cancer cell lines [166]. Besides this, honeybees 
prepare a sticky substance (called propolis/bee glue) by mixing 
saliva poplar tree resin; this natural product shows therapeutic 
benefits against breast cancer. Milestone is also used as a 
Promising Adjuvant treatment for brain tumors [167-169]. Till date 
so many major toxins/allergens have been identified in many 
species of wasps and bees, which are of very high medical 
importance [170, 171]. These toxins have been characterized for 
their biological activity and their differential gene profiling has been 
done [172, 173]. There is need of molecular docking important data 
on toxins for development of effective therapeutics through 
A combination of transcriptomic, proteomic, peptidomic, glycemic 
and venomic approaches [174, 175] (fig. 3). More often, the data 
available in various databases on peptide toxins can be used for 
comparative transcriptome analysis of the venom sac and 
gland of several species [176-178]. It will assist in identifying its 
confirmatory biological activity in animal models [179, 180]. These 
toxin peptides can be used to develop new diagnostic and 
therapeutic approaches for the treatment of poisonous animal stings 
and bites [181]. Production of anti-venom serum against important 
toxins and allergens can be used in immunotherapy to encounter 
envenomation (table 3; fig. 3). Severe allergies or allergies may not 
be completely relieved by other treatments; hence, allergen 
immunotherapy can be applied. It involves a series of injections of 
purified allergen extracts, usually given over a period of a few years. 
No doubt hornet, honey bee and wasp venoms are of therapeutic 
and biotechnological use. 
 
Table 1: Toxins found in wasp venom allergens and their molecular weight and biological effects 
Species Toxin Mw Biological effects Source 
Vespa, protopolybia Kinnin and polyamines 32,000 Cytotoxic, anticancer 24 
Vespa flavitarsus Hornetin 32,000 Antimicrobial, anticancer, neurotoxicity  25 
Vespa vulagaris Hyluronidase A  43000 Cytotoxic  98 
Polibia polista Cationicpepetides (Polibia MP-1) 1611.98 Antifungal 120 
Bees Phospholipase A2 16000 
14500 (−CHO) 
Hydrolysis of lecithins 174 
Bees, wasps Hyaluronidase 43000 
39000 (−CHO) 
Allergenic activity 174 
Bees Acid phosphatase 48000 (monomer) Inflammation, coagulation factor, apoptosis 
of ovarian cells, antimicrobial activity 
174 
Honeybees Melittin 11360 (tetramer) cytotoxic effect 174 
Bumblebees Tryptic amidase 27250 Proteolytic activity 174 
Wasps, ants Phospholipase A1B 33500 Allergenic activity 174 
Wasps, ants Antigen 5 23000 Pain, allergenic activity 174 
Fire ants Sol 2 26432 (dimer) Antimicrobial activity 174 
Fire ants Sol i 4 13340 Antimicrobial activity 174 
Jack-jumper and bulldog ants Myr p 1 9103 (precursor) Antimicrobial activity 174 
Jack-jumper and bulldog ants Myr p 2 8144 (precursor) Antimicrobial activity 174 
 
 
Fig. 1: Hymenopteran venom toxins and its constituent molecules 
Table 2: Showing major hymenopteran insect venom derived toxins/allergen with their major biological activity 
S. No. Species name Common name Allergen type Biological activity Source 
1. Vespa 
mandarinia 
Asian giant hornet Allergen5, chemotactic peptide  Inflammatory activity, antimicrobial 
activity, causes allergic reaction in human 
1 
2. Vespa velutina Asian predatory 
wasp 
Agatoxinlike, analgesic polypeptide, 
oriento toxin like peptide 
Hemolytic activity, paralysis (calcium 
channel blocking), 
5 
4. Vespa bicolor 
 
Black shield wasp Mastoparan 
 
Allergic inflammation (mast cell 
degranulation) 
5 
5. Vespa crabo, European hornet 
 
Calsyntenin, leucine-rich repeat 
domain containing protein 
Paralysis (calcium channel blocking), 
antimicrobial activity 
5 
6. Vespa 
xanthoptera 
Japanese yellow 
hornet  
chemotactic peptide  Inflammatory activity, antimicrobial activity 5 
7. Vespa affinis 
 
Lesser banded 
hornet 
Phospholipase A1 Production of lipid mediator 6 
8. 
 
Vespa 
germanica 
German or 
European wasp 
Allergen 5 Allergenic activity 7 
9. Agelia pallipes Agalia Wasp chemotactic peptide Allergenic inflammation 
Antimicrobial activity, mast cell 
degranulation 
7 
10. Agelia vicina  AV, Tx 7,8 Paralysis (K+channel blocking) 7 
11. Dolicho vespula 
maculate 
Yellowjackets Allergen 5 Allergenic activity 7 
12. Vespa orientalis Oriental hornet Oriento toxin like peptide Paralysis (pre-synaptic effect, 
lysophospholipase activity  
19 
13. Protopolibia 
exigua 
Neotropical social 
wasp 
Mastopran Allergic inflammation, mast cell 
degranulation 
24 
14. Polistes 
infuscatus 
Golden or 
northern paper 
wasp 
Allergen5, wasp kinin Pain, allergenic activity 19 
15 Polistes 
infuscatus 
Paper wasp Wasp kinin,mastoparan Pain production, allergic inflammation(mast 
cell degranulation) 
19 
16 Polistes 
jadwiqae 
Paper wasp 
 
Wasp kinin,mastoparan Pain production, allergic inflammation(mast 
cell degranulation) 
19 
17. Paravespula 
lewisii 
Yellowjackets  Wasp chemotactic peptide Inflammatory activity, antimicrobial activity 19 
18.  Paravespula 
maculifrons 
Western yellow 
jackets 
Wasp kinin Pain production 19 
19. Protonectarina 
sylveira 
Brazilian wasp Wasp chemotactic peptide Inflammatory activity, antimicrobial activity 48 
20. Polistes 
exclamans 
Paper wasp 
 
Wasp kinin, allergen 5 Pain production, allergenic activity 89 
21.  Vespa tropica Oriental hornet Wasp kinin, mastoparan  Pain production, Allergic inflammation 
(mast cell degranulation) 
99 
22. Polistes major Paper wasp Wasp kinin Pain production 90 
32. Vespa basalis Black-bellied 
hornet 
Dipeptidyl peptidase IV Metabolism of organic compound  120 
23. Ropalidia Yellow jackets Mastoparan Allergenic inflammation(mast cell de-
granulation) 
170, 171 
24. Vespa 
xanthoptera 
Japanese yellow 
hornet 
Wasp kinin, Mastoparan Pain production, allergenic 
inflammation(mast cell degranulation) 
170, 171 
25. Vespa analis Yellow-vented 
hornet 
Leucine-rich repeat domain 
containing protein, wasp kinin, 
mastopran, acetylcholinesterases, 
Paralysis, pain, allergic, hemolytic factor, 
inflammatory response, synaptic 
organization, coagulation factor 
170, 171 
26 
. 
Vespa ducalis  Mastoparan Allergic inflammation (mast cell 
degranulation 
170, 171 
27. Vespa 
flavopilosa 
Red wasp Allergen 5 Allergenic activity 170, 171 
28. Vespula lewisii Italian wasp Mastoparan Allergic inflammation (mast cell 
degranulation 
170, 171 
29. Vespula 
pensylvanica 
Western yellow 
jacket 
Allergen 5 Allergenic activity 170, 171 
30. Vespula 
squamosa 
Southern yellow 
jacket 
Allergen 5 Allergenic activity 170, 171 
31. Vespula vidua Long yellow jacket 
or widow yellow 
jacket 
Allergen 5 Allergenic activity 170, 171 
 
 
Table 3: Toxin peptides found in various species of wasp, bee and hornet with its biological activities 
Species Peptides Biological activities References 
Eumenes pomiformis Dendrotoxin-like Paralysis (K+channel blocking) 175, 177 
Anterhynechium flavomarginatum Mastoparan-like Allergic inflammation Antimicrobial activity 175, 177 
Cyphononyx fulvognathus Wasp chemotactic peptide Inflammatory activity Antimicrobial activity 175, 177 
Orancistro cerus drewseni Tyrosine 3-monooxygenase Regulation of dopamine synthesis 175, 177 
Orancistro cerus drewseni Rhynchium 
brunneum 
Actin Regulation of hemocyte cytoskeleton gene 
expression 
175 
Orancistrocerus dresweri Arginine kinase Paralysis 175 
Rhynchiumbrunneum ATP synthase ATP synthesis 176, 177 
Eumenes pomiformis Alcohol dehydrogenase Oxidation of ethanol to acetaldehyde 177 
Eumene spomiformis Glutamate decarboxylase Involvement in beta-cell-specific 
autoimmunity 
177 
Eumenespomiformis Insulin-like peptide-binding 
protein 
Developmental arrest (Inhibition of insulin 
signaling) 
177 
Eumene spomiformis HECT E3 ubiquitin ligase Regulation of cell trafficking 177 
Eumene spomiformis Hyaluronidase Venom dissemination 177, 178 
Rhynchium brunneum Farnesoic acid O-
methyltransferase 
Regulation of biosynthetic pathway of juvenile 
hormone 
178 
Rhynchium brunneum Acetyl-CoA synthase Involvement in metabolism of acetate 178 
Rhynchium brunneum Amidophosphoribosyltransferase Regulation of cell growth 178 
Rhynchium brunneum Cytochrome P450 monooxygenase Metabolism of toxic compounds 178 
Rhynchium brunneum Carboxylesterase Lipid metabolism 178 
Rhynchium brunneum Citrate synthase Catalyzing the citric acid cycle 178 
Rhynchium brunneum DNA-directed RNA polymerase Synthesis of mRNA precursor 178 
Rhynchium brunneum Glyceraldehyde-3-phosphate 
dehydrogenase 
Direct hemolytic factor 178 
Rhynchium brunneum Glycogenin Synthesis of glycogen 178 
Rhynchium brunneum Myo inositol monophosphatase Regulation of inositol homeostasis 178 
Rhynchium brunneum  
Eumenespomiformis 
Phospholipase A2 Hydolysis of lecithins 177, 178 
Rhynchium brunneum Protein tyrosin phosphatase Regulation of cellular processes 178 
Rhynchium brunneum Serine/threonine-protein 
phosphatase 
Regulation of biochemical pathways 178 
Orancistro cerus drewseni Metalloendopeptidase Inhibition of platelet aggregation 177, 178 
Rhynchium brunneum Neprilysin Inhibition of platelet aggregation 178 
Rhynchium brunneum Ankyrin Attachment of membrane proteins to 
membrane cytoskeleton 
178  
Orancistro cerus drewseni Rhynchium 
brunneum 
Bmkettin Development of flight muscles 176, 178 
Orancistro cerus drewseni Rhynchium 
brunneum 
Eumenespomiformis 
Calponin Regulation of myogenesis 176, 178 
Orancistro cerus drewseni Rhynchium 
brunneum 
Eumenespomiformis 
Muscle LIM protein Regulation of myogenesis 176, 178 
Orancistro cerus drewseni 
Eumenes pomiformis 
Muscle protein 20 Myomesin Regulation of muscle contraction 176, 178 
Rhynchium brunneum Myosin heavy chain Regulation of muscle functions 179 
Orancistroceru drewseni Rhynchium 
brunneum 
Eumenes pomiformis 
Myosin light chain Modulation of the affinity of myosin for actin 176, 178 
Orancistr oceru sdrewseni Rhynchium 
brunneum Eumenespomiformis 
Paramyosin Regulation of thick filament in muscles 176, 178 
Orancistrocerus drewseni Rhynchium 
brunneum Eumenespomiformis 
Titin Assembly of contractile machinery in muscle 
cells 
176, 178 
Orancistro cerus drewseni Rhynchium 
brunneum 
Tropomyosin Muscle contraction  176, 178 
Orancistro cerusdrewseni Rhynchium 
brunneum 
Troponin Muscle contraction 176, 178 
Orancistrocerus drewseni Rhynchium 
brunneum Eumenespomiformis 
Tubulin Regulation of hemocyte skeleton genes 
expression 
176, 178 
Rhynchium brunneum Chemosensory protein Transferring metabolism-related small 
molecules 
178 
Orancistrocerusdrewseni Rhynchium 
brunneum 
Cytochrom C Protein wire 176, 178 
Orancistro cerus drew seni Rhynchium 
brunneum 
Eumenes pomiformis 
Heat shock proteins 
 
Prevention of protein misfolding 175, 178 
Rhynchium brunneum Sialin Nitrate transporter 179 
Rhynchium brunneum Sugar transporter Maintenance of glucose homeostasis 179 
Batozonellusmaculifrons β-pompilidiotoxin Paralysis (Na+channel blocking) 181 
Anoplius samariensis α-pompilidiotoxin Paralysis (Na+channel blocking) 181 
 
Fig. 2: Hymenopteran venom toxins and its various biological activities 
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Fig. 3: Hymenopteran venom toxins and its effect on vital organ systems 
 
CONCLUSION  
Hymenoptera venom is a complex mixture of many substances such 
as toxins, enzymes, growth factor activators, and inhibitors. It 
contains few biologically important enzymes, i.e. phospholipases 
acid phosphatase, Proteases and therapeutically important peptides 
such as Mastoparan-C (MP-C), scapin A, apamin, Mast cell 
degranulating (MCD) peptide, Bradykinin, AMPs which display 
diverse therapeutic potential. Hymenopteran insect venom toxins 
are highly specific as they show diversity in structure and function. 
Insect venom is a good source of proteinaceous toxins and enzymes 
mainly smaller protein toxins, and non-proteinaceous molecules. 
These components are highly active toxic agents as they generate 
multiple clinical and pathophysiological changes such as severe 
inflammation and pain. Bee venom is also used in healing treatment 
for various disorders. More especially bio-molecules found in 
hornets, bees and wasps have shown anti-tumor and anti-cancer 
activity, antioxidant, anti-parasitic, antiseptic, proteolytic, catalytic, 
hemotoxic, neuro-inhibitor, anticancer, antimicrobial, immune 
hypersensitive, inflammatory, antimicrobial and anti-insect 
activities. Insects possess anti-parasitic peptides which show much 
wider application in alternate drug therapy. These compounds are 
used as an alternative medicine for the treatment of protozoa-related 
diseases, mainly caused by endemic parasites: Leishmania 
sp., Plasmodium sp., and Trypanosomes. Honey bee venom shows an 
anti-parasitic effect against Entamoeba histolytica and Giardia lamblia 
trophozoites in the sub-culture method due to quick transport through 
a membrane or their binding. Venom toxin structures are also 
important and there is a need to make interconnection among 
biochemistry, pharmacology and immunology areas for the expansion 
of knowledge and for the generation of innovation in the field of 
therapeutic and pharmaceutical research. 
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